Please assess the completion status of the following clinical trial:

Trial Title: Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria::~* age 18 - 65 inclusive~* able to read and understand informed consent~* informed consent given~* currently being treated with an SSRI for depression or dysthymia~* currently suffering from treatment-emergent sexual dysfunction attributable to the SSRI~* have normal safety lab values at screen~* if currently taking medication to improve sexual performance, willing to discontinue the drug for the duration of the study~* female subjects of child bearing age need to use an acceptable form of birth control throughout the study Exclusion Criteria:- being pregnant, breastfeeding, or planning to become pregnant within 4 months~* suffering from psychotic, substance abuse, bipolar, or organic mental disorder, OCD, panic disorder, or personality disorder severe enough to interfere with study participation~* suffer from an unstable or serious medical disorder~* having a medical disorder that could be the cause of the sexual dysfunction~* taking a medication that is metabolized by hepatic enzyme CYP2D6~* having used a MAOI within 15 days of proposed start of duloxetine treatment~* having a known hypersensitivity to duloxetine or any of its ingredients~* having taken viagra or related drug within 3 months prior to starting SSRI treatment~* requiring ongoing treatment with a mood stabilizer (anticonvulsant) or antipsychotic medication

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Duloxetine (Type: EXPERIMENTAL): Duloxetine 60 mg, by mouth, once daily or twice daily (as needed to control symptoms of major depression)

Based on this trial design, predict the completion outcome and termination type (if applicable).